All cell lines expressed comparable levels of wild-type MET without gene amplification (Fig. 4H), despite having diverse mutations or copy number variations in known cancer driver genes (Dietlein et al, 2020) (Fig. 4I). The gene discussed is MET; the disease is cancer.